| Titre : | Ginkgo biloba in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. A randomized, placebo-controlled, trial (2015) |
| Auteurs : | Fereshteh Shakibaei, Auteur ; Mehrsa Radmanesh, Auteur ; Elham Salari, Auteur ; et al., Auteur |
| Type de document : | Article |
| Dans : | Complementary Therapies in Clinical Practice (Vol. 19, May 2015) |
| Article en page(s) : | p. 61-67 |
| Langues: | Anglais |
| Descripteurs : |
HE Vinci Adolescent ; Enfant (6-12 ans) ; Ginkgo biloba ; Phytotherapie ; Placebo ; Recherche ; Thérapeutique ; Thérapies complémentaires ; Trouble déficitaire de l'attention avec ou sans hyperactivité |
| Résumé : |
Objective
To evaluate the efficacy of Ginkgo biloba as a complementary therapy for attention-deficit/hyperactivity disorder (ADHD). Methods Children and adolescents with ADHD received methylphenidate (20–30 mg/day) plus either G. biloba (80–120 mg/day) or placebo for 6 weeks. Parent and teacher forms of the ADHD Rating Scale-IV (ADHD-RS-IV) were completed at baseline, week 2, and week 6. Treatment response was defined as 27% improvement from baseline in the ADHD-RS-IV. Results Compared with placebo, more reduction was observed with G. biloba regarding ADHD-RS-IV parent rating inattention score (−7.74 ± 1.94 vs. −5.34 ± 1.85, P Conclusions The G. biloba is an effective complementary treatment for ADHD. Further studies with longer treatment duration are warranted in this regard. IRCT2014111519958N1. |
| Disponible en ligne : | Non |
Exemplaires (1)
| Cote | Support | Localisation | Section | Disponibilité |
|---|---|---|---|---|
| REV | Périodique papier | Woluwe | Espace revues | Consultation sur place uniquement Exclu du prêt |
